Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$118M |
| 2 |
JPMorgan Chase
JPM
|
+$87.7M |
| 3 |
Bank of America
BAC
|
+$66.7M |
| 4 |
Citigroup
C
|
+$58.3M |
| 5 |
Wells Fargo
WFC
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$227M |
| 2 |
Johnson & Johnson
JNJ
|
+$198M |
| 3 |
Coca-Cola
KO
|
+$184M |
| 4 |
PepsiCo
PEP
|
+$179M |
| 5 |
McDonald's
MCD
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.91% |
| 2 | Healthcare | 19.75% |
| 3 | Financials | 10.48% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
J.M. Smucker
SJM
$12.8B
| $36.7M | 0.2% |
231,482
-54,947
| -19% | -$8.19M |
|
102
Progressive
PGR
$125B
| $36.6M | 0.2% |
282,290
+111,376
| +65% | +$14.1M |
|
103
Zillow
Z
$7.56B
| $36.2M | 0.2% |
1,124,552
+40,624
| +4% | +$1.35M |
|
104
Li Auto
LI
$12.7B
| $35.7M | 0.19% |
1,748,817
-1,528,232
| -47% | -$29.1M |
|
105
Goldman Sachs
GS
$303B
| $34.6M | 0.19% |
100,908
+84,715
| +523% | +$29.5M |
|
106
SLB Ltd
SLB
$75B
| $34.5M | 0.19% |
644,781
+272,080
| +73% | +$13.5M |
|
|
HOLX
107
DELISTED
Hologic
HOLX
| $33.4M | 0.18% |
446,060
-153,339
| -26% | -$10.9M |
|
108
Labcorp
LH
$25.9B
| $33M | 0.18% |
163,281
-35,247
| -18% | -$6.89M |
|
109
Darden Restaurants
DRI
$24.4B
| $32.5M | 0.18% |
235,143
-76,280
| -24% | -$10.6M |
|
110
Hormel Foods
HRL
$13.8B
| $31.9M | 0.17% |
700,686
-154,920
| -18% | -$7.21M |
|
111
Extra Space Storage
EXR
$31.6B
| $31.7M | 0.17% |
215,260
+29,629
| +16% | +$4.74M |
|
112
Archer Daniels Midland
ADM
$36.9B
| $31.5M | 0.17% |
339,384
-151,474
| -31% | -$14M |
|
113
Invitation Homes
INVH
$18B
| $31.5M | 0.17% |
1,061,904
+176,081
| +20% | +$5.58M |
|
114
US Bancorp
USB
$99.6B
| $30.8M | 0.17% |
705,795
+330,660
| +88% | +$14.2M |
|
115
Biogen
BIIB
$30.7B
| $30.7M | 0.17% |
110,797
-2,826
| -2% | -$798K |
|
116
Quest Diagnostics
DGX
$26.3B
| $30.5M | 0.17% |
195,023
+33,728
| +21% | +$4.85M |
|
117
ConocoPhillips
COP
$141B
| $30.4M | 0.17% |
257,225
-175,073
| -40% | -$21.3M |
|
118
Lamb Weston
LW
$7.19B
| $30.3M | 0.17% |
339,630
-73,418
| -18% | -$6.25M |
|
119
Vertex Pharmaceuticals
VRTX
$126B
| $29.1M | 0.16% |
100,819
-63,172
| -39% | -$19.3M |
|
120
Kanzhun
BZ
$7.36B
| $29M | 0.16% |
1,422,142
+138,217
| +11% | +$2.27M |
|
121
CoStar Group
CSGP
$12.3B
| $28.9M | 0.16% |
373,677
-166,011
| -31% | -$13M |
|
122
IBM
IBM
$224B
| $28.7M | 0.16% |
203,464
+14,909
| +8% | +$2.06M |
|
123
Corteva
CTVA
$51.3B
| $28.2M | 0.15% |
479,415
-93,090
| -16% | -$5.89M |
|
124
Regeneron Pharmaceuticals
REGN
$80.8B
| $28.1M | 0.15% |
38,881
-18,596
| -32% | -$13.7M |
|
125
Fidelity National Information Services
FIS
$22.1B
| $28M | 0.15% |
412,718
+200,597
| +95% | +$14.3M |
|
Similar funds
Ray Dalio's Q4 2022 Portfolio in Review
As of Q4 2022, Ray Dalio held 953 positions worth $18.3B, down 7.3% from $19.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $3.25B in Q4 2022, closing 133 positions and reducing 457 holdings. Its most notable exit was Advanced Micro Devices, an estimated $45.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ray Dalio opened a new position in JPMorgan Chase worth $92.8M.
- Ray Dalio's largest Q4 2022 buy was JPMorgan Chase: 692,356 shares worth $92.8M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $118M increase.
- Ray Dalio's biggest Q4 2022 reduction was Procter & Gamble, cutting an estimated $227M.
- Ray Dalio fully exited Advanced Micro Devices in Q4 2022, selling an estimated $45.8M.
- Ray Dalio's ten largest holdings make up 32% of its $18.3B portfolio in Q4 2022.
- Ray Dalio opened 87 new positions and closed 133 in Q4 2022.
- Ray Dalio's portfolio value fell 7.3% quarter-over-quarter to $18.3B.
Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.